AU5613394A - 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors - Google Patents

17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors

Info

Publication number
AU5613394A
AU5613394A AU56133/94A AU5613394A AU5613394A AU 5613394 A AU5613394 A AU 5613394A AU 56133/94 A AU56133/94 A AU 56133/94A AU 5613394 A AU5613394 A AU 5613394A AU 5613394 A AU5613394 A AU 5613394A
Authority
AU
Australia
Prior art keywords
steroidals
diene
carboxy
alpha
reductase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56133/94A
Other languages
English (en)
Inventor
Dennis Alan Holt
Mark Alan Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224213A external-priority patent/GB9224213D0/en
Priority claimed from GB939316954A external-priority patent/GB9316954D0/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU5613394A publication Critical patent/AU5613394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0014Androstane derivatives substituted in position 17 alfa, not substituted in position 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU56133/94A 1992-11-18 1993-11-18 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors Abandoned AU5613394A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9224213 1992-11-18
GB929224213A GB9224213D0 (en) 1992-11-18 1992-11-18 Compounds
GB9316954 1993-08-14
GB939316954A GB9316954D0 (en) 1993-08-14 1993-08-14 Compounds
PCT/US1993/011225 WO1994011004A1 (en) 1992-11-18 1993-11-18 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors

Publications (1)

Publication Number Publication Date
AU5613394A true AU5613394A (en) 1994-06-08

Family

ID=26302003

Family Applications (2)

Application Number Title Priority Date Filing Date
AU56133/94A Abandoned AU5613394A (en) 1992-11-18 1993-11-18 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors
AU56717/94A Abandoned AU5671794A (en) 1992-11-18 1993-11-18 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU56717/94A Abandoned AU5671794A (en) 1992-11-18 1993-11-18 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase

Country Status (12)

Country Link
EP (2) EP0673251A1 (enExample)
JP (1) JPH08503471A (enExample)
CN (2) CN1101916A (enExample)
AP (1) AP9300589A0 (enExample)
AU (2) AU5613394A (enExample)
CA (1) CA2149427A1 (enExample)
IL (1) IL107611A0 (enExample)
MA (1) MA23036A1 (enExample)
MX (1) MX9307203A (enExample)
NZ (1) NZ258723A (enExample)
SI (1) SI9300601A (enExample)
WO (2) WO1994011386A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
WO1996011206A1 (en) * 1994-10-05 1996-04-18 Smithkline Beecham Corporation Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
DE69824632T2 (de) 1997-11-12 2005-06-09 Mitsubishi Chemical Corp. Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
WO2000068231A1 (en) 1999-05-11 2000-11-16 Mitsubishi Chemical Corporation Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5137882A (en) * 1990-06-11 1992-08-11 Holt Dennis A Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors
CA2045866A1 (en) * 1990-06-28 1991-12-29 Gary H. Rasmusson 17-beta-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5 alpha-reductase inhibitors
CA2045865A1 (en) * 1990-06-28 1991-12-29 Gary H. Rasmusson Intermediates on the synthesis of 17 beta-acyl-3-carboxy-androsta-3,5-dienes
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
US5196411A (en) * 1991-08-16 1993-03-23 Merck & Co., Inc. 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
CN1101914A (zh) 1995-04-26
EP0673251A1 (en) 1995-09-27
CN1101916A (zh) 1995-04-26
WO1994011386A1 (en) 1994-05-26
EP0669932A1 (en) 1995-09-06
AU5671794A (en) 1994-06-08
AP9300589A0 (en) 1994-01-31
CA2149427A1 (en) 1994-05-26
EP0673251A4 (enExample) 1995-10-25
JPH08503471A (ja) 1996-04-16
MA23036A1 (fr) 1994-07-01
MX9307203A (es) 1994-07-29
NZ258723A (en) 1996-12-20
IL107611A0 (en) 1994-02-27
EP0669932A4 (en) 1995-10-25
SI9300601A (en) 1994-06-30
WO1994011004A1 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
AU4251993A (en) Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors
HK1000242B (en) Topical terbinafine compositions
AU652227B2 (en) Thickeners for products for topical application
AU3105493A (en) Quinolone- and naphthyridone-carboxylic acid derivatives
AU2645692A (en) Composition comprising s-oxiracetame for use as nootropic
ZA943561B (en) Topical composition for inhibiting hair growth
AU4120193A (en) Biphenyl derivatives
AU3803593A (en) Compounds
AU4771393A (en) Refrigerant compositions including 1,1,2,2-tetrafluoroethane
AU2888292A (en) Toiletries composition
AU1282795A (en) Prostaglandin derivative, salt thereof, and use thereof
AU3108293A (en) Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives
AU1629792A (en) Gallium compounds
AU5613394A (en) 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors
AU4760193A (en) Antioxidant
AU2723292A (en) Acetylene compounds
AU2875992A (en) Di-tert-butylphenol compounds useful as anti-inflammatory agents
AU6571594A (en) Thioindole pyperidinyl derivatives used as antalgics
AU7398794A (en) 7-substituted-delta4-6-azasteroid derivatives as 5alpha-reductase inhibitors
AU7314594A (en) Triazole-derived acid-esters or ester-amide-amine salts as antiwear additives
AU5884694A (en) Low soap bar composition
AU3629593A (en) Iso-cyclosporin salts
AU6413594A (en) Substituted 3-phenanthridinone derivatives as 5alpha-reductase inhibitors
AU8133294A (en) 7beta -substituted-4-aza-5alpha-cholestan-3-ones as selective 5alpha-reductase 1 inhibitors
AU3048492A (en) New compounds